Infolek

Text je určený pre medicínskych profesionálov.

Nadpis je samozrejme hyperbolou. No pomaly si budeme naozaj klásť otázky: Ešte aké ďalšie choroby bude tento liek liečiť, kým ho označíme na všeliek? Kam až bude siahať redukcia dávky, ktorá prinesie ďalšiu a ďalšiu indikáciu.

Nie sme už naozaj na konci? (obrazne aj doslova)

Low-dose aspirin (75 mg/day) may protect against colorectal cancer, according to the results of a case-control study reported online September 15 in Gut.

“Previous studies have shown that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) lower colorectal cancer (CRC) risk,” write Farhat V. N. Din, from the University of Edinburgh, Edinburgh, United Kingdom, and colleagues. “However, the lowest effective NSAID dose, treatment duration, and effects on survival are not defined. In a large population-based case-control study, we have explored the relationship between NSAID dose and duration, CRC risk and overall CRC-specific survival.”

Low-Dose Aspirin May Protect Against Colorectal Cancer